Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Using multiple cards for rewards can significantly boost your benefits. Find out how to optimize your spending for maximum returns.
17,302 articlesLilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
A wave of data center spending powered by AI is reshaping the investment landscape. This article explains which stock...
When a top executive sells nearly 5,000 shares of Alpha and Omega Semiconductor, investors pause. This article breaks...
Two tech giants pull back in divergent fashion. This report analyzes valuations, AI upside, and cash flow to help ret...
Memory markets are shifting as mega-capex from Hynix and Samsung could ease shortages. Here's what that means for Mic...
Investors are eyeing yuanbao (yb) 2026 earnings as the company pivots toward new revenue streams. This guide breaks d...
As AMD gears up for its Aug. 4 earnings release, the stock’s unstoppable momentum raises questions: what would truly ...
Lemonade's shares swung wildly in a single session, rising on an earnings beat and then tumbling as expectations cool...
When Apple moves more of its production to the U.S., investors often respond quickly. This article explains why apple...
You might have retirement savings you don’t realize exist. Old 401(k)s, IRAs, and other accounts can quietly sit unus...
Pulmonx is navigating a pivotal year as it advances its lung care devices while contending with pacing competition an...
A booming memory era presents both opportunities and risks for Micron. This guide breaks down the potential, the cata...